Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Unmet needs of multiple sclerosis patients in the community.

Lonergan R, Kinsella K, Fitzpatrick P, Duggan M, Jordan S, Bradley D, Hutchinson M, Tubridy N.

Mult Scler Relat Disord. 2015 Mar;4(2):144-50. doi: 10.1016/j.msard.2015.01.003. Epub 2015 Feb 3.

PMID:
25787190
2.

Paraneoplastic dentate ganglionopathy: clinical and neuroimmunologic studies.

O'Toole O, Murphy O, O'Dwyer J, Lonergan R, Keogh B, Tubridy N, Lynch T, Farrell M.

Clin Neuropathol. 2015 January/February;34(1):34-38.

PMID:
25074875
3.

Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.

McNulty JP, Lonergan R, Brennan PC, Evanoff MG, O'Laoide R, Ryan JT, Tubridy N.

Clin Neuroradiol. 2014 Mar 6. [Epub ahead of print]

PMID:
24599322
4.

Frequent inaccuracies in ABCD2 scoring in non-stroke specialists' referrals to a daily Rapid Access Stroke Prevention service.

Bradley D, Cronin S, Kinsella JA, Tobin WO, Mahon C, O'Brien M, Lonergan R, Cooney MT, Kennelly S, Collins DR, O'Neill D, Coughlan T, Smyth S, McCabe DJ.

J Neurol Sci. 2013 Sep 15;332(1-2):30-4. doi: 10.1016/j.jns.2013.05.030. Epub 2013 Jul 17.

PMID:
23871489
5.

Symptom overlap in anxiety and multiple sclerosis.

Ó Donnchadha S, Burke T, Bramham J, O'Brien MC, Whelan R, Reilly R, Kiiski H, Lonergan R, Kinsella K, Kelly S, McGuigan C, Hutchinson M, Tubridy N.

Mult Scler. 2013 Sep;19(10):1349-54. doi: 10.1177/1352458513476742. Epub 2013 Feb 14.

PMID:
23413298
6.

Only low frequency event-related EEG activity is compromised in multiple sclerosis: insights from an independent component clustering analysis.

Kiiski H, Reilly RB, Lonergan R, Kelly S, O'Brien MC, Kinsella K, Bramham J, Burke T, O Donnchadha S, Nolan H, Hutchinson M, Tubridy N, Whelan R.

PLoS One. 2012;7(9):e45536. doi: 10.1371/journal.pone.0045536. Epub 2012 Sep 21.

7.

Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.

McKenna MJ, Murray B, Lonergan R, Redmond JM.

Ir J Med Sci. 2013 Mar;182(1):29-32. doi: 10.1007/s11845-012-0818-5. Epub 2012 Apr 7.

PMID:
22484845
8.

Change in PASAT performance correlates with change in P3 ERP amplitude over a 12-month period in multiple sclerosis patients.

Kiiski H, Reilly RB, Lonergan R, Kelly S, O'Brien M, Kinsella K, Bramham J, Burke T, O'Donnchadha S, Nolan H, Hutchinson M, Tubridy N, Whelan R.

J Neurol Sci. 2011 Jun 15;305(1-2):45-52. doi: 10.1016/j.jns.2011.03.018. Epub 2011 Mar 31.

PMID:
21457995
9.

IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells.

Sweeney CM, Lonergan R, Basdeo SA, Kinsella K, Dungan LS, Higgins SC, Kelly PJ, Costelloe L, Tubridy N, Mills KH, Fletcher JM.

Brain Behav Immun. 2011 Aug;25(6):1170-81. doi: 10.1016/j.bbi.2011.03.007. Epub 2011 Mar 21.

PMID:
21420486
10.

Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype.

Lonergan R, Kinsella K, Fitzpatrick P, Brady J, Murray B, Dunne C, Hagan R, Duggan M, Jordan S, McKenna M, Hutchinson M, Tubridy N.

J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):317-22. doi: 10.1136/jnnp.2010.220988. Epub 2011 Jan 19.

PMID:
21248317
11.

OAS1: a multiple sclerosis susceptibility gene that influences disease severity.

O'Brien M, Lonergan R, Costelloe L, O'Rourke K, Fletcher JM, Kinsella K, Sweeney C, Antonelli G, Mills KH, O'Farrelly C, Hutchinson M, Tubridy N.

Neurology. 2010 Aug 3;75(5):411-8. doi: 10.1212/WNL.0b013e3181ebdd2b.

PMID:
20679634
12.

Preliminary evidence for correlation between PASAT performance and P3a and P3b amplitudes in progressive multiple sclerosis.

Kiiski H, Whelan R, Lonergan R, Nolan H, Kinsella K, Hutchinson M, Tubridy N, Reilly RB.

Eur J Neurol. 2011 May;18(5):792-5. doi: 10.1111/j.1468-1331.2010.03172.x.

PMID:
20666835
13.

Impaired information processing speed and attention allocation in multiple sclerosis patients versus controls: a high-density EEG study.

Whelan R, Lonergan R, Kiiski H, Nolan H, Kinsella K, Hutchinson M, Tubridy N, Reilly RB.

J Neurol Sci. 2010 Jun 15;293(1-2):45-50. doi: 10.1016/j.jns.2010.03.010.

PMID:
20399448
14.

A high-density ERP study reveals latency, amplitude, and topographical differences in multiple sclerosis patients versus controls.

Whelan R, Lonergan R, Kiiski H, Nolan H, Kinsella K, Bramham J, O'Brien M, Reilly RB, Hutchinson M, Tubridy N.

Clin Neurophysiol. 2010 Sep;121(9):1420-6. doi: 10.1016/j.clinph.2010.03.019. Epub 2010 Apr 8.

PMID:
20381418
15.

Discontinuing disease-modifying therapy in progressive multiple sclerosis: can we stop what we have started?

Lonergan R, Kinsella K, Duggan M, Jordan S, Hutchinson M, Tubridy N.

Mult Scler. 2009 Dec;15(12):1528-31. doi: 10.1177/1352458509351730. Epub 2009 Dec 7.

PMID:
19995848
16.

CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.

Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH.

J Immunol. 2009 Dec 1;183(11):7602-10. doi: 10.4049/jimmunol.0901881. Epub 2009 Nov 16.

17.

Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) in a sibling pair with a homozygous p.A467T POLG mutation.

McHugh JC, Lonergan R, Howley R, O'Rourke K, Taylor RW, Farrell M, Hutchinson M, Connolly S.

Muscle Nerve. 2010 Feb;41(2):265-9. doi: 10.1002/mus.21494.

PMID:
19813183
18.

Generating hand dysaesthesiae: the "GHD phenomenon" - straight to the diagnosis.

Lonergan R, Gorman G, Alexander MD, Killeen R, de Blacam C, Tubridy N.

BMJ Case Rep. 2009;2009. pii: bcr02.2009.1544. doi: 10.1136/bcr.02.2009.1544. Epub 2009 Jun 1.

19.

CT guided aspiration of a cervical spinal epidural abscess.

Rust TM, Kohan S, Steel T, Lonergan R.

J Clin Neurosci. 2005 May;12(4):453-6.

PMID:
15925781
20.

Paraspinal abscess complicating facet joint injection.

Magee M, Kannangara S, Dennien B, Lonergan R, Emmett L, Van der Wall H.

Clin Nucl Med. 2000 Jan;25(1):71-3. No abstract available.

PMID:
10634544
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk